Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
Z Baretta, S Mocellin, E Goldin, OI Olopade, D Huo - Medicine, 2016 - journals.lww.com
Background: The contribution of BRCA germline mutational status to breast cancer patients'
prognosis is unclear. We aimed to systematically review and perform meta-analysis of the …
prognosis is unclear. We aimed to systematically review and perform meta-analysis of the …
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the …
F Kamangar, GM Dores, WF Anderson - Journal of clinical oncology, 2006 - ascopubs.org
Efforts to reduce global cancer disparities begin with an understanding of geographic
patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and …
patterns in cancer incidence, mortality, and prevalence. Using the GLOBOCAN (2002) and …
Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR
Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …
beginning at age 40 for women of average risk and earlier and/or more intensive screening …
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
The COVID-19 pandemic presents clinicians a unique set of challenges in managing breast
cancer (BC) patients. As hospital resources and staff become more limited during the COVID …
cancer (BC) patients. As hospital resources and staff become more limited during the COVID …
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 …
N Mavaddat, D Barrowdale, IL Andrulis… - … Biomarkers & Prevention, 2012 - AACR
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors
differ in their pathology. Analysis of larger datasets of mutation carriers should allow further …
differ in their pathology. Analysis of larger datasets of mutation carriers should allow further …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer
CK Kuhl, S Schrading, CC Leutner… - Journal of clinical …, 2005 - ascopubs.org
Purpose To compare the effectiveness of mammography, breast ultrasound, and magnetic
resonance imaging (MRI) for surveillance of women at increased familial risk for breast …
resonance imaging (MRI) for surveillance of women at increased familial risk for breast …
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller, JM Silva, G Dominguez… - JNCI: Journal of the …, 2000 - academic.oup.com
Background: Inherited mutations in the BRCA1 gene may be responsible for almost half of
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …
inherited breast carcinomas. However, somatic (acquired) mutations in BRCA1 have not …
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial
C Kuhl, S Weigel, S Schrading, B Arand… - Journal of Clinical …, 2010 - ascopubs.org
Purpose We investigated the respective contribution (in terms of cancer yield and stage at
diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality …
diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality …
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with …
SR Lakhani, MJ Van De Vijver, J Jacquemier… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: The morphologic and molecular phenotype of breast cancers may help identify
patients who are likely to carry germline mutations in BRCA1 and BRCA2. This study …
patients who are likely to carry germline mutations in BRCA1 and BRCA2. This study …